Data / Drug companies / Shenzhen Alvantis Pharma Co., Ltd.
Shenzhen Alvantis Pharma Co., Ltd.: 29 products in the FDA NDC directory, labeler code 84347
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Shenzhen Alvantis Pharma Co., Ltd. (labeler code 84347) lists 29 products in the FDA National Drug Code Directory. By type: 29 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 27, 2026.
The request: Watch Shenzhen Alvantis Pharma Co., Ltd. (FDA labeler code 84347): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84347
- Products in commercial distribution
- 29
- Packages
- 177
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 14
- Earliest marketing start
- May 23, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 72.4% |
| Bulk ingredients for compounding | 8 | 27.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 29 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 29 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tb500 fragment acetate | 84347-113 | Powder | Bulk ingredients | October 27, 2026 |
| Ghk-cu acetate | 84347-105 | Powder | Bulk ingredients | October 14, 2026 |
| Thymosin beta-4 acetate | 84347-215 | Powder | Bulk ingredients for compounding | September 1, 2026 |
| Mots-c acetate | 84347-214 | Powder | Bulk ingredients for compounding | August 20, 2026 |
| Ipamorelin | 84347-213 | Powder | Bulk ingredients for compounding | June 15, 2026 |
| Bpc-157 arginate | 84347-112 | Powder | Bulk ingredients for compounding | May 11, 2026 |
| Bpc-157 acetate | 84347-111 | Powder | Bulk ingredients for compounding | May 11, 2026 |
| Epitalon | 84347-212 | Powder | Bulk ingredients | March 30, 2026 |
| Dsip | 84347-211 | Powder | Bulk ingredients | March 30, 2026 |
| Nicotinamide adenine dinucleotide | 84347-210 | Powder | Bulk ingredients | March 4, 2026 |
| Semax | 84347-209 | Powder | Bulk ingredients | March 4, 2026 |
| Tb500 fragment | 84347-208 | Powder | Bulk ingredients | January 27, 2026 |
| Elamipretide | 84347-008 | Powder | Bulk ingredients | January 27, 2026 |
| Cjc-1295 | 84347-206 | Powder | Bulk ingredients | January 4, 2026 |
| Thymosin alpha-1 | 84347-205 | Powder | Bulk ingredients | July 22, 2025 |
| Dihexa | 84347-204 | Powder | Bulk ingredients | July 22, 2025 |
| Copper peptide (ghk-cu) | 84347-203 | Powder | Bulk ingredients | July 22, 2025 |
| Argireline | 84347-202 | Powder | Bulk ingredients | July 22, 2025 |
| Aod 9604 | 84347-104 | Powder | Bulk ingredients | February 17, 2025 |
| Bpc-157 | 84347-102 | Powder | Bulk ingredients | February 17, 2025 |
| Cagrilintide | 84347-007 | Powder | Bulk ingredients | February 17, 2025 |
| Tesamorelin | 84347-006 | Powder | Bulk ingredients | February 17, 2025 |
| Sermorelin acetate | 84347-005 | Powder | Bulk ingredients | February 17, 2025 |
| Bremelanotide acetate | 84347-004 | Powder | Bulk ingredients | February 17, 2025 |
| Retatrutide | 84347-003 | Powder | Bulk ingredients | February 17, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.